Literature DB >> 16614609

[Chikungunya on Reunion Island: chronicle of an epidemic foretold].

Fabrice Paganin1, Giannandrea Borgherini, Frédéric Staikowsky, Claude Arvin-Berod, Patrice Poubeau.   

Abstract

Chikungunya is a viral disease transmitted by a mosquito of the genus Aedes. It is currently epidemic on Reunion Island, in the Indian Ocean. It is essentially characterized by an influenza syndrome but associated with polyarthralgia and an eruption. The disabling and chronic nature of the arthralgia is the most remarkable clinical aspect of chikungunya infection. Severe and unusual forms have appeared, not previously described in the literature. These forms must be studied to determine whether there is a direct relation between the chikungunya virus and the severity factors. Treatment is solely symptomatic, combining analgesic and/or antiinflammatory agents. There is no vaccine. The epidemic is not limited to Reunion: cases of chikungunya have also been reported in neighboring islands (Maurice, Seychelles, and Madagascar). Travelers planning to visit the region should be counseled.

Entities:  

Mesh:

Year:  2006        PMID: 16614609     DOI: 10.1016/s0755-4982(06)74657-7

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  9 in total

1.  Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.

Authors:  Sharmila Nair; Subhajit Poddar; Raeann M Shimak; Michael S Diamond
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

2.  Placental Alterations in a Chikungunya-Virus-Infected Pregnant Woman: A Case Report.

Authors:  Natália Salomão; Luciana Araújo; Kíssila Rabelo; Elyzabeth Avvad-Portari; Luiz de Souza; Regina Fernandes; Nathália Valle; Luiz Ferreira; Carlos Basílio-de-Oliveira; Rodrigo Basílio-de-Oliveira; Thiara de Souza; Priscila Nunes; Jorge Carvalho; Flavia Dos Santos; Marciano Paes
Journal:  Microorganisms       Date:  2022-04-22

3.  Reemergence of endemic Chikungunya, Malaysia.

Authors:  Sazaly AbuBakar; I-Ching Sam; Pooi-Fong Wong; Noraziyah MatRahim; Poh-Sim Hooi; Nuruliza Roslan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

4.  Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells.

Authors:  Yong-Gang Li; Uamporn Siripanyaphinyo; Uranan Tumkosit; Nitchakarn Noranate; Atchareeya A-Nuegoonpipat; Yang Pan; Masanori Kameoka; Takeshi Kurosu; Kazuyoshi Ikuta; Naokazu Takeda; Surapee Anantapreecha
Journal:  Virol J       Date:  2012-06-14       Impact factor: 4.099

5.  Chikungunya disease outbreak, Reunion Island.

Authors:  Loïc Josseran; Christophe Paquet; Abdelkrim Zehgnoun; Nadège Caillere; Alain Le Tertre; Jean-Louis Solet; Martine Ledrans
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

6.  Modeling dynamic introduction of Chikungunya virus in the United States.

Authors:  Diego Ruiz-Moreno; Irma Sanchez Vargas; Ken E Olson; Laura C Harrington
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

7.  Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.

Authors:  Patrick Gérardin; Georges Barau; Alain Michault; Marc Bintner; Hanitra Randrianaivo; Ghassan Choker; Yann Lenglet; Yasmina Touret; Anne Bouveret; Philippe Grivard; Karin Le Roux; Séverine Blanc; Isabelle Schuffenecker; Thérèse Couderc; Fernando Arenzana-Seisdedos; Marc Lecuit; Pierre-Yves Robillard
Journal:  PLoS Med       Date:  2008-03-18       Impact factor: 11.069

8.  A single mutation in chikungunya virus affects vector specificity and epidemic potential.

Authors:  Konstantin A Tsetsarkin; Dana L Vanlandingham; Charles E McGee; Stephen Higgs
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

9.  Assessing Chikungunya risk in a metropolitan area of Argentina through satellite images and mathematical models.

Authors:  Diego Ruiz-Moreno
Journal:  BMC Infect Dis       Date:  2016-02-01       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.